Heather Preston

Heather Preston joined the Board of Oxford Science Enterprises in late 2021. She is an experienced biotechnology venture capitalist with over 30 years of healthcare experience as a scientist, physician and management consultant. She is currently a Managing General Partner of Pivotal BioVenture Partners, a San Francisco based venture capital fund focused on investing in innovative therapeutics and therapeutic platforms. Prior to joining Pivotal, she was a Firm Partner and Managing Director at TPG Biotech. Prior to this, Heather spent two years with JP Morgan Partners, was an Entrepreneur-in-Residence with New Enterprise Associates and spent five years at McKinsey & Co., leading the pharmaceutical and medical products consulting practice. Heather has an undergraduate degree in biochemistry form from the University of London and a medical degree from the University of Oxford. She completed a post-doctoral fellowship in molecular biology at the Dana Farber Cancer Institute, Harvard University and trained in Internal Medicine at the Massachusetts General Hospital, Harvard.